Filter by:
Eyewire News
Maria Berrocal, MD and Jordan Deaner, MD
Eyetube
This tried-and-true tool may be a valuable tamponade alternative.
Lawrence Chan, MD; Tanner Frediani, MD; and Gaurav K. Shah, MD
Retina Today
Proliferative disease may still be progressing despite good vision.
Apoorva Jadhav, MBBS, DNB; Unnikrishnan Nair, MS, FRCS, FMRF; and Manoj Soman, DNB, FICO, FRCS
As part of our 20th anniversary, Retina Today is digging into the archives to reflect on how much the profession has changed.
Michael S. Ip, MD
Even with the advances in imaging technology, fundus autofluorescence remains integral to our imaging protocols. Here’s why.
Thomas Ach, MD, MSc, FEBO, and Andreas Pollreisz, MD
Our findings suggest certain dietary and lifestyle habits may confer long-term protective benefits.
Christopher Phung, BA; Beryl Zhou, BS; Robert Luca, BA; and Dimitra Skondra, MD, PhD
Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.
Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD
Photobiomodulation shows promise, but long-term data are needed.
Luis Acabá-Berrocal, MD, and Anton Orlin, MD
Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD
Know the clinical risk factors for the development of malignancy.
Henry M. Nguyen, BS; Aruba Zafar, MD; Robert J. Medina, BA; and Carol L. Shields, MD
The pipeline is full of therapies that hold promise for extending treatment efficacy.
Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi
Kevin J. Corcoran, COE, CPC, CPMA, FNAO
View More
New Retina Radio is a place to hear stories about retina that are told nowhere else.
The RETINAWS panel led by Kourous Rezaei, MD, discuss techniques for vitreoretinal surgery and rare surgical cases.